Chronic high Epstein‐Barr viral load carriage in pediatric liver transplant recipients
Authors:
- 2 April 2009
- journal article
- Published by Wiley in Pediatric Transplantation
- Vol. 13 (3) , 319-323
Abstract
Abstract: Development of EBV disease and PTLD is usually accompanied by the detection of a high EBV load in peripheral blood. However, many children undergoing primary EBV infection following LTx will maintain chronically elevated EBV loads in the absence of clinical symptoms. To better understand this phenomenon, we retrospectively reviewed the records of children undergoing LTx at our center from 1997 to 2007 to identify chronic high EBV load carriers in this population. A CHL state was defined by the presence of a high load for >50% of samples for greater than or equal to six months following either asymptomatic or complete clinical resolution of EBV disease/PTLD. A total of 35 CHL carriers were identified. Pretransplant serologies were available for 29 of the 35; 22/29 (76%) were EBV negative prior to LTx; eight of these 22 developed their CHL state at the time of their primary EBV infection. Fourteen of the 35 had EBV disease (n = 7) or PTLD (n = 7) prior to development of the CHL state. Only one of 35 CHL carriers developed PTLD or lymphoma while they were a high load carrier. In all, 23/35 resolved their CHL state without apparent sequelae while 11 children continue to be asymptomatic high load carriers. These data provide important information about the outcome of chronic EBV high load carriage in pediatric liver transplant recipients.Keywords
This publication has 14 references indexed in Scilit:
- Chronic High Epstein-Barr Viral Load State and Risk for Late-Onset Posttransplant Lymphoproliferative Disease/Lymphoma in ChildrenAmerican Journal of Transplantation, 2008
- Persistent Increased Epstein-Barr Virus Loads After Solid Organ TransplantationLiver Transplantation, 2007
- Post‐Transplant Lymphoproliferative Disorders and Malignancy2007
- CMV-IVIG for Prevention of Epstein Barr Virus Disease and Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant RecipientsAmerican Journal of Transplantation, 2006
- Risk factors for post‐transplant lymphoproliferative disorder in pediatric patients: A case‐control studyPediatric Transplantation, 2005
- Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCRJournal of Clinical Microbiology, 2003
- Epstein‐Barr Virus Gene Expression in the Peripheral Blood of Transplant Recipients with Persistent Circulating Virus LoadsThe Journal of Infectious Diseases, 2000
- The role of viral load in the diagnosis, management, and possible prevention of Epstein-Barr virus–associated posttransplant lymphoproliferative disease following solid organ transplantationCurrent Opinion in Organ Transplantation, 1999
- PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1Transplantation, 1998
- SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1Transplantation, 1998